Showing results (811-820 of 1,130) with videos related to
Sort By:
Pageof 113
The Biochemical Journal|June 5, 2014
miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxiaLucio Iannone, Lan Zhao, Olivier Dubois, et al.Open Forum Infectious Diseases|August 19, 2022
Role of Therapeutic Drug Monitoring in the Treatment of Persistent Mycobacterium abscessus Central Nervous System Infection: A Case Report and Review of the LiteratureEn-Ling Wu, Omar Al-Heeti, Brian M Hoff, et al.Nature Communications|August 31, 2021
NTS Prlh overcomes orexigenic stimuli and ameliorates dietary and genetic forms of obesityWenwen Cheng, Ermelinda Ndoka, Jessica N Maung, et al.Infection Control and Hospital Epidemiology|May 4, 2017
A Simple Microsoft Excel Method to Predict Antibiotic Outbreaks and UnderutilizationCristina Miglis, Nathaniel J Rhodes, Sean N Avedissian, et al.The Journal of the American Osteopathic Association|October 3, 2007
Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot studyBrian F Degenhardt, Nissar A Darmani, Jane C Johnson, et al.Bioorganic & Medicinal Chemistry Letters|September 20, 2011
Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategyLawrence J Wilson, Bingbing Wang, Shyh-Ming Yang, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 19, 2001
Kinetic modulation of Kv4-mediated A-current by arachidonic acid is dependent on potassium channel interacting proteinsM H Holmqvist, J Cao, M H Knoppers, et al.Journal of Hospital Medicine|April 13, 2025
Impact of an electronically-integrated clinical pathway on hospital initiation of medications for alcohol use disorder and subsequent hospital utilizationKelsey O Cole, Melissa B Weimer, Kaicheng Wang, et al.Biorxiv : the Preprint Server for Biology|April 10, 2026
A novel mechanism of ceftolozane-tazobactam resistance in Pseudomonas aeruginosa mediated by L2 β-lactamasePreeti Garai, Sophia H Nozick, Caroline C Jozefczyk, et al.Pharmacotherapy|June 11, 2026
Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?Jonathan H Ryder, Shawnalyn W Sunagawa, Nathaniel J Rhodes, et al.Pageof 113